Significant Drug Interaction: Use Caution with Hydroxyzine and Gabapentin Together
Yes, there is a clinically significant interaction between hydroxyzine and gabapentin due to additive central nervous system (CNS) depression effects, and their concurrent use requires dose reduction and careful monitoring.
Primary Interaction Mechanism
Both medications are CNS depressants that can potentiate each other's sedative effects 1, 2. The FDA label for hydroxyzine explicitly warns that "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS" and states that "when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced" 1.
Clinical Implications
Expected Additive Effects:
- Enhanced somnolence and sedation - Gabapentin causes somnolence in 19-21% of patients (vs 5-9% placebo), and hydroxyzine is inherently sedating 2
- Increased dizziness - Gabapentin causes dizziness in 17-28% of patients 2
- Impaired driving ability - Gabapentin alone causes significant driving impairment; this risk is amplified when combined with hydroxyzine 2
- Confusion and over-sedation, particularly in elderly patients 1
Additional Safety Concerns:
The 2019 AGS Beers Criteria specifically warns about "concurrent use of a combination of three or more central nervous system (CNS) agents (antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, antiepileptics, and opioids)" increasing fall risk 3. While this combination involves only two agents, the principle of additive CNS depression applies.
Gabapentin should be used with caution when combined with other sedating drugs "because of potential synergy" 2.
Practical Management Algorithm
If concurrent use is necessary:
Reduce initial doses of both medications below standard starting doses 1
- Start hydroxyzine at the low end of dosing range
- Start gabapentin at 100-200 mg/day (lower than typical starting doses) 4
Titrate slowly with extended monitoring intervals between dose increases 4
Warn patients explicitly about:
Monitor closely for:
- Excessive sedation or confusion
- Respiratory depression (though rare with this combination alone)
- Falls and injuries
Use extra caution in elderly patients - start at lowest possible doses and observe closely, as elderly patients are particularly vulnerable to sedation and confusion 1
Common Pitfall to Avoid
Do not assume these medications are "safe" simply because neither is an opioid or benzodiazepine. The FDA explicitly categorizes both as CNS depressants requiring dose adjustment when used together 1, 2. The interaction is pharmacodynamic (additive effects) rather than pharmacokinetic, meaning it occurs regardless of metabolism or drug levels.